FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/1/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/1/2017     P    1000   A $0.0948   20522949   D    
Common Stock   5/1/2017     P    1000   A $0.0918   20523949   D    
Common Stock   5/1/2017     P    1000   A $0.092   20524949   D    
Common Stock   5/1/2017     P    1000   A $0.0895   20525949   D    
Common Stock   5/1/2017     P    1000   A $0.085   20526949   D    
Common Stock   5/1/2017     P    1000   A $0.085   20527949   D    
Common Stock   5/1/2017     P    1000   A $0.086   20528949   D    
Common Stock   5/1/2017     P    1000   A $0.085   20529949   D    
Common Stock   5/1/2017     P    1000   A $0.083   20530949   D    
Common Stock   5/1/2017     P    1000   A $0.082   20531949   D    
Common Stock   5/1/2017     P    1000   A $0.082   20532949   D    
Common Stock   5/1/2017     P    1000   A $0.082   20533949   D    
Common Stock   5/1/2017     P    1000   A $0.083   20534949   D    
Common Stock   5/1/2017     P    1000   A $0.0879   20535949   D    
Common Stock   5/1/2017     P    1000   A $0.0878   20536949   D    
Common Stock   5/2/2017     P    1000   A $0.082   20537949   D    
Common Stock   5/2/2017     P    1000   A $0.0808   20538949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20539949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20540949   D    
Common Stock   5/2/2017     P    1000   A $0.0807   20541949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20542949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20543949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20544949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20545949   D    
Common Stock   5/2/2017     P    500   A $0.081   20546449   D    
Common Stock   5/2/2017     P    500   A $0.081   20546949   D    
Common Stock   5/2/2017     P    1000   A $0.0807   20547949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20548949   D    
Common Stock   5/2/2017     P    1000   A $0.081   20549949   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 5/4/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.